Report Store Get Proposal

Home Blog Notizia 34

Notizia - Recent Pharma, Healthcare and Biotech Happenings

medtech-news-updates-for-boston-scientific-kestra-zoll-fujifilm-cytosorbents-lunit

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Boston Scientific’s EkoSonic; FDA clearance for EXALT; Kestra Medical’s ASSURE; ZOLL Next-Generation remedē system; CytoSorbents’ DrugSorb-ATR; Fujifilm-Lunit collaboration

Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic™ Endovascular System On August 04, 2021, Boston Scientific Corporation started the enrolment in the HI-PEITHO clinical trial, which is a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing the use of the EkoSonic™ Endovascular System (EKOS) in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE). The trial will enroll around 544 patients with confirmed acute, ...

Explore More...

Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal

NASH

Notizia

The Business Cocktail

Inozyme Raises $67M; Shanghai Miracogen partners with Synaffix; EdiGENE raises $15M; Antengene announces its expansion

Notizia

the business cocktail

AgomAb Therapeutics raises $23.5M; Allergan’s eye drug; Good news for the patients; Dyne Therapeutics comes to life

Multiple Sclerosis

Notizia

artificial intelligence

The Business Cocktail

stem cell therapy

Notizia

merck

The Business Cocktail

cystic fibrosis

Approach for Cystic Fibrosis; An alternative for Statins; Oral medications not safe; Carbon monoxide poisoning treatment gets approval

mRNA

BioNTech lines up $800M; Deerfield remunerates; Britain’s Smith & Nephew to acquire Osiris

Notizia

mRNA

Biogen buys Nightstar; Pacira acquires Myoscience; Horizon Pharma announces pricing; STAT with Slingshot Insights; Epizyme announces Equity Offering

common cold

ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness

The Business Cocktail

CRISPR

Notizia

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly